hepatitis%20-%20viral
HEPATITIS - VIRAL
The majority of acute viral hepatitis infections are asymptomatic or they can cause an anicteric illness that may not be diagnosed as hepatitis.
Hepatitis A generally causes minor illness in childhood with >80% of infections being asymptomatic but more likely to produce clinical symptoms in adults. 
Hepatitis B, C, & D may also be asymptomatic.
Hepatitis A is predominantly transmitted through oral-fecal route.
Hepatitis B is transmitted through perinatal, percutaneous, or sexual routes or close person-to-person contact via open cuts and sores.
Hepatitis C infections are transmitted through perinatal, percutaneous, or sexual routes, blood transfusions, or organ transplants.
Hepatitis D's route of transmission is sexual or percutaneous, especially IV drug use.
Hepatitis E is transmitted primarily through contaminated drinking water and oral-fecal transmission.

Introduction

  • A self-limiting disease that is usually caused by viruses. As it progresses, it causes fibrosis (scarring), cirrhosis & cancer of the liver

Signs and Symptoms

  • The majority of acute viral hepatitis infections are asymptomatic or they can cause an anicteric illness that may not be diagnosed as hepatitis
  • Hepatitis A generally causes minor illness in childhood w/ >80% of infections being asymptomatic
    • Adults are more likely to produce clinical symptoms
  • Hepatitis B, C & D may also be asymptomatic
  • Symptomatic hepatitis B will depend on the mode & time of transmission
    • Vertical transmission from mother to child is almost always asymptomatic
    • Other routes of transmission are more likely to produce symptomatic disease (30% of cases transmitted by IV drug use are icteric)
Preicteric Phase
  • Nonspecific systemic symptoms (eg myalgia, nausea, vomiting, fatigue, malaise w/ discomfort in the right upper quadrant of the abdomen)
  • Altered sense of smell or taste, coryza, photophobia, headache, cough, diarrhea, dark urine & serum sickness-like syndrome
  • Hepatomegaly, splenomegaly & lymphadenopathy may be seen on physical exam
Icteric Phase
  • Jaundice, usually noted after onset of fever or upon lysis of fever
Fulminant Hepatitis
  • Development of symptoms of hepatic encephalopathy (eg confusion, drowsiness w/in 8 wk of symptoms or w/in 2 wk of onset of jaundice)
  • Hypoglycemia, prolonged prothrombin time (PT)

Pathogenesis

Routes of Transmission of Hepatitis

Hepatitis A: Oral-fecal

Hepatitis B: Perinatal, percutaneous, sexual, close person-to-person contact ie by open cuts & sores

Hepatitis C: Blood transfusions, organ transplants, percutaneous (esp IV drug use), sexual, perinatal

Hepatitis D: Sexual, percutaneous esp IV drug use

  • Found only in patients w/ hepatitis B since it requires the hepatitis B outer coat

Hepatitis E: Oral-fecal, blood transfusion in endemic areas

Incubation Period

Hepatitis A: 15-50 days

Hepatitis B: 40-180 days

Hepatitis C: 20-120 days

Hepatitis D: 30-180 days

Hepatitis E: 21-60 days

Other Characteristics of Hepatitis Viruses

  • Hepatitis B virus contains a DNA nucleic acid while A, C, & E viruses have an RNA nucleic acid
    • Hepatitis D has an incomplete RNA & needs the B virus to replicate
  • Hepatitis A & E viruses cause epidemics
  • Hepatitis B, C, & D viruses may predispose to chronic disease & hepatic malignancy
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Hepatology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Pank Jit Sin, 2 years ago
Diagnosis and treatment of NAFLD isn’t always precise, but new developments are helping to pave the way for better management of the disease, shares a panel of experts. 
3 years ago
Treatment with low-dose on-demand hepatitis B immunoglobulin added to entecavir led to decreased hepatitis B virus (HBV) recurrence rate without development of resistance following liver transplantation, according to an assessment of a pilot study.
one year ago
Sanofi’s approach in providing medical education has evolved over the years, by not only limiting the content to disease management and patient outcomes, but also taking into consideration of the various challenges faced by doctors across the different sectors. 
2 years ago
The antiviral efficacy and safety of tenofovir with or without addition of lamivudine or telbivudine was compared in patients with lamivudine-resistant chronic hepatitis B.